OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
July 08, 2021
LGM Pharma will offer contract analytical testing and stability services to pharmaceutical developers and manufacturers.
June 01, 2021
The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
May 16, 2021
The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.
Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
May 02, 2021
Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.
March 01, 2021
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.
February 04, 2021
PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.
January 28, 2021
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.